Work

Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma

Year: 2008

Type: review

Source: Nature Reviews Drug Discovery

DOI: 10.1038/nrd2664

Authors: Hans-Georg Eichler, Francesco Pignatti, Bruno Flamion, Hubert Leufkens, Alasdair Breckenridge

Institutions: European Medicines Agency, University of Namur, Utrecht University, Medicines Evaluation Board, Medicines and Healthcare products Regulatory Agency

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2067460372

FWCI: 4.794

Cites: 36

Cited by: 229

Related to: 10